Last reviewed · How we verify

NCT06704997

Machine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation

Active, enrolled Last updated 27 November 2024
What this trial tests

trial in Stroke in 10,000 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 June 2024
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorTan Tock Seng Hospital
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment10,000
Start date1 June 2024
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across Singapore

Conditions studied

Sponsor

Tan Tock Seng Hospital

Who can join

Adults 21 to 100, any sex, with Stroke or Acquired Brain Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this retrospective study is to ascertain total direct costs, rehabilitation length of stay (RLOS) and factors associated with RLOS for neurological inpatient rehabilitation at the tertiary care hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Tan Tock Seng Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06704997.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing